Market Segmentation Overview By product type , the GLP-1 receptor agonists segment led the GLP-1 market with an 86% share in 2025, due to the continued adoption of diabetes management and weight loss
For Washington State residents exploring Medigap options alongside drug coverage, our Washington Medicare Plan Options for 2026 guide covers the full landscape of choices available this year
The choice of alternative therapy should be individualised based on glycaemic control requirements, cardiovascular risk profile, renal function, patient preferences, and other clinical factors, in accordance with NICE guidance (NG28: Type 2 diabetes in adults: management)
The procedure takes 3045 minutes, depending on the target area
Does it help build habits that last
Modulation of reactive oxygen species in health and disease